Seizures Drug Pipeline Analysis 2024: By Clinical Trial Phase: Late-Stage Products (Phase III and Phase IV), Mid-Stage Products (Phase II), Early-Stage Products (Phase I), Preclinical and Discovery Stage Products; By Therapy Type: Monotherapy, Combination Therapy; By Drug Class: Sodium Channel Blockers, Calcium Channel Blockers, Gamma-Aminobutyric Acid (GABA), Enhancers Glutamate Receptor Antagonists; Route of Administration; Drug Profile; Key Players

Datasheet

$ 1999.00